References
- Pammi M, Garley JE, Carlin EM. Pregnancy outcomes of HIV-positive women in a tertiary centre in the UK. J Obstet Gynaecol 2015;35:136–8.
- Ikechebelu JI, Ugboaja JO, Kalu SO, Ugochukwu EF. The outcome of Prevention of Mother–To–Child Transmission (PMTCT) of HIV Infection Programme in Nnewi, Southeast Nigeria. Niger J Med 2011;20:421–5.
- Minkoff H, Burns DN, Landesman S, et al. The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am J Obstet Gynecol 1995;173:585–9.
- Landesman SH, Kalisha LA, Burns DN, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study. N Engl J Med 1996;334:1617–23.
- International Perinatal HIV Group. Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies. AIDS 2001;15:357–68.
- Aagaard-Tillery K, Lin MG, Lupo V, et al. Clinical study – preterm premature rupture of membranes in human immunodeficiency virus infected women: a novel case series. Infect Dis Obstet Gynecol 2006;2006:53234.
- Alvarez JR, Bardeguez A, Iffy L, Apuzzio JJ. Preterm premature rupture of membranes in pregnancies complicated by human immunodeficiency virus infection: a single center’s five-year experience. J Matern Fetal Neonatal Med 2007;20:853–7.
- Melamed N, Ben-Haroush A, Pardo J, et al. Expectant management of preterm premature rupture of membranes: is it all about gestational age? Am J Obstet Gynecol 2011;204:48.e1.
- UNAIDS 2014; Gap report. Available at: http://www.unaids.org/en/resources/campaigns/2014/2014gapreport/gapreport. Assessed on 14th November, 2015.
- Agboghoroma CO, Sagay SA, Ikechebelu JI. Nigerian prevention of mother to child transmission of human immunodeficiency virus program: the journey so far. J HIV Hum Reprod 2013;1:1–7.
- Sagay AS, Ebonyi AO, Meloni ST, et al. Mother-to-child transmission outcomes of HIV-exposed infants followed up in Jos North-Central Nigeria. Curr HIV Res 2015;13:193–200.
- Eleje GU, Onwusulu DN, Ezeama CO, et al. Perceptions of focused prenatal care among women attending two tertiary centers in Nigeria. Int J Gynaecol Obstet 2015;131:174–7.
- Adesina OA, Michael OS, Ogunbosi BO, et al. Obstetrics and newborn outcomes and risk factors for low birth weight and preterm delivery among HIV-infected pregnant women at the University College Hospital, Ibadan. Trop J Obstet Gynaecol 2015;32:64–74.
- Federal Ministry of Health, Nigeria. National Guidelines for Prevention of mother-to-child-transmission (PMTCT) of HIV, 2010.
- Eleje G, Ele P, Okocha E, Iloduba U. Epidemiology and clinical parameters of adult human immunodeficiency virus/acquired immunodeficiency syndrome at the initiation of antiretroviral therapy in South eastern Nigeria. Ann Med Health Sci Res 2014;4:217–21.
- Mark S, Murphy KE, Read S, et al. HIV mother-to-child transmission, mode of delivery, and duration of rupture of membranes: experience in the current era. Infect Dis Obstet Gynecol 2012;2012:267969.
- Briand N, Jasseron C, Sibiude J, et al. Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010. Am J Obstet Gynecol 2013;209:335.e1–335.e12.
- European Collaborative Study, Boer K, England K, Godfried MH, Thorne C. Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe. HIV Med 2010;11:368–78.
- WHO PMTCT guidelines. Available from: http://www.avert.org/professionals/hiv-prevention-programming/prevention-mother-child/guidelines, 2016.
- World Health Organisation (WHO). Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV, 2015.
- Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Antiretrovirals for reducing the risk of mother-to child transmission of HIV infection. Cochrane Database Syst Rev 2011;(7):CD003510. doi:10.1002/14651858.CD003510.pub3.
- Giorgi JV, Lyles RH, Matud JL, et al. Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr 2002;29:346–55.
- Abimiku A, Villalba-Diebold P, Dadik J, et al. Risk factors associated with low CD4+ lymphocyte count among HIV-positive pregnant women in Nigeria. Int J Gynaecol Obstet 2009;106:227–31.
- Rawizza HE. Toward Eliminating Pediatric HIV Infection: Medscape, May 30, 2012.
- Sibanda EL, Weller IV, Hakim JG, Cowan FM. The magnitude of loss to follow-up of HIV-exposed infants along the prevention of mother-to-child HIV transmission continuum of care: a systematic review and meta-analysis. AIDS 2013;27:2787–97.